BioJapan 2025

이벤트:

BioJapan is Asia's premier bio-industry partnering event, bringing together global leaders through an exhibition, seminars, and one-to-one partnering sessions. As the world’s longest-running biotech exhibition, BioJapan, together with its co-located events Regenerative Medicine Japan and healthTECH Japan, drives industry collaboration and accelerates innovation across biotechnology, regenerative medicine, health management, diagnostics, and therapeutics.

Novotech is pleased to participate, with Dr. Yooni Kim, Managing Director, Asia Pacific, Marina Mullins, Head of Therapeutic Strategy, and Calvin Tzeng, Business Development Director, Ming Lee, Business Development Manager in attendance. Our team looks forward to engaging with biotech and pharma leaders to explore opportunities for advancing clinical programs in Asia-Pacific and globally.

Novotech Capabilities:

• Recognized as a leading global CRO with deep expertise in managing complex, multi-country clinical trials.
• Trusted partner to biotech and pharma companies worldwide, delivering agile, high-quality solutions from early to late phase development.

Meet Novotech at the Australian Embassy Booth (D-125) or connect with our team through the Partnering Platform.